Sonoma Pharmaceuticals Inc. Live Stock Price Today, Share Analysis and Chart

Name: Sonoma Pharmaceuticals Inc.: Is Infosys Ltd. worth buying?
Item: Sonoma Pharmaceuticals Inc.
Rating: 2.55958325
Author: Trendlyne DVM scores

about

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focu...

4.46 -0.10 (-2.19%)

35.55% Fall from 52W High

31,826

XNAS Volume

XNAS 29 Aug, 2025 11:53 AM (EDT)

Not Eligible

Expensive Valuation

25.8 / 100

Technically Bullish

76.6 / 100

1Yr Price target upside is 232%

1 analysts

Sonoma Pharmaceuticals Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Sonoma Pharmaceuticals Inc. Live Stock Price Today, Share Analysis and Chart

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focu...

35.55% Fall from 52W High

SWOT Analysis

Sonoma Pharmaceuticals Inc. Live Price Chart